C07K 2318/10
Immunoglobulin or domain thereof as scaffolds for inserted non-ig peptide sequences
Official title: Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
C07K2318/10 (Immunoglobulin or domain thereof as scaffolds for inserted non-ig peptide sequences) appears on 115 US grants and 227 published applications in this corpus.
Search patents in C07K- Granted patents
- 115
- Published applications
- 227
- Assignees
- 113
- Inventors
- 420
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 5 |
| 2004 | 1 | 5 |
| 2005 | 2 | 6 |
| 2006 | 1 | 10 |
| 2007 | 4 | 7 |
| 2008 | 3 | 3 |
| 2009 | 1 | 25 |
| 2010 | 14 | 6 |
| 2011 | 2 | 7 |
| 2012 | 0 | 2 |
| 2013 | 4 | 7 |
| 2014 | 8 | 11 |
| 2015 | 2 | 11 |
| 2016 | 7 | 9 |
| 2017 | 6 | 10 |
| 2018 | 6 | 9 |
| 2019 | 6 | 9 |
| 2020 | 15 | 13 |
| 2021 | 4 | 20 |
| 2022 | 4 | 11 |
| 2023 | 6 | 10 |
| 2024 | 6 | 8 |
| 2025 | 9 | 17 |
| 2026 | 4 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Humanized antibodies with ultralong complementary determining regions21 Apr 2026US 12,606,937 B2Taurus Biosciences, LLC
- Meditope-enabled T cells31 Mar 2026US 12,590,137 B2City of Hope
- Antibodies that bind adenosine A2A receptors and methods of use thereof to treat cancer and neurological diseases10 Mar 2026US 12,570,750 B2Twist Bioscience Corporation
- TGF-β polypeptides20 Jan 2026US 12,528,850 B2Cue Biopharma, Inc.
- C-based single domain antibody for neutralizing respiratory syncytial virus and application thereof9 Sep 2025US 12,410,242 B2Wuhan Banke Biotechnology Co., Ltd.
- Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (sars) coronavirus infection10 Sep 2026US 2026/0263588 A1Phylex Biosciences, Inc.
- Fc region-based heterodimer molecule and use thereof10 Sep 2026US 2026/0265361 A1
- Antibody-like molecule comprising heterodimer of human cd1b (cluster of differentiation 1) protein20 Aug 2026US 2026/0242492 A1Joint Stock Company “Biocad”
- Vaccine comprising an antibody or an fc-containing fusion protein comprising an fc part of an antibody1 Jan 2026US 2026/0001939 A1Heidelberg ImmunoTherapeutics GmbH
- Binding proteins comprising an anti-immune checkpoint antibody or a fragment thereof and single-chain tnfrsf ligand multimers25 Dec 2025US 2025/0388676 A1
Most cited
By later US patents
- Modified Fc molecules114US 7,442,778 B2Amgen Inc. · 2008
- Therapeutic antibodies71US 7,465,790 B2Isis Innovation Limited · 2008
- Modified Fc molecules53US 7,662,931 B2Amgen Inc. · 2010
- Modified Fc molecules50US 7,750,128 B2Amgen Inc. · 2010
- Dock-and-lock (DNL) complexes for delivery of interference RNA41US 8,491,914 B2IBC Pharmaceuticals, Inc. · 2013